Cargando…

Efficacy, Retention, and Tolerability of Brivaracetam in Patients With Epileptic Encephalopathies: A Multicenter Cohort Study From Germany

Objective: To evaluate the efficacy and tolerability of brivaracetam (BRV) in a severely drug refractory cohort of patients with epileptic encephalopathies (EE). Method: A multicenter, retrospective cohort study recruiting all patients treated with EE who began treatment with BRV in an enrolling epi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Willems, Laurent M., Bertsche, Astrid, Bösebeck, Frank, Hornemann, Frauke, Immisch, Ilka, Klein, Karl M., Knake, Susanne, Kunz, Rhina, Kurlemann, Gerhard, Langenbruch, Lisa, Möddel, Gabriel, Müller-Schlüter, Karen, von Podewils, Felix, Reif, Philipp S., Steinhoff, Bernhard J., Steinig, Isabel, Rosenow, Felix, Schubert-Bast, Susanne, Strzelczyk, Adam
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Neurology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6064736/ https://www.ncbi.nlm.nih.gov/pubmed/30083127 http://dx.doi.org/10.3389/fneur.2018.00569

Ejemplares similares

First clinical postmarketing experiences in the treatment of epilepsies with brivaracetam: a retrospective observational multicentre study
por: Menzler, Katja, et al.
Publicado: (2019)

Brivaracetam in the Treatment of Patients with Epilepsy—First Clinical Experiences
por: Zahnert, Felix, et al.
Publicado: (2018)

Socioeconomic Outcome and Quality of Life in Adults after Status Epilepticus: A Multicenter, Longitudinal, Matched Case–Control Analysis from Germany
por: Kortland, Lena-Marie, et al.
Publicado: (2017)

Direct and indirect costs and cost-driving factors in adults with tuberous sclerosis complex: a multicenter cohort study and a review of the literature
por: Zöllner, Johann Philipp, et al.
Publicado: (2021)

Quality of life and its predictors in adults with tuberous sclerosis complex (TSC): a multicentre cohort study from Germany
por: Zöllner, Johann Philipp, et al.
Publicado: (2021)

Brivaracetam substituting other antiepileptic treatments: Results of a retrospective study in German epilepsy centers
por: Lerche, Holger, et al.
Publicado: (2020)

Efficacy, Retention and Tolerability of Everolimus in Patients with Tuberous Sclerosis Complex: A Survey-Based Study on Patients’ Perspectives
por: Willems, Laurent M., et al.
Publicado: (2021)

Adverse Event Profiles of Antiseizure Medications and the Impact of Coadministration on Drug Tolerability in Adults with Epilepsy
por: Willems, Laurent M., et al.
Publicado: (2023)

Efficacy, Tolerability, and Safety of Concentrated Intranasal Midazolam Spray as Emergency Medication in Epilepsy Patients During Video-EEG Monitoring
por: von Blomberg, Anemone, et al.
Publicado: (2020)

A Prospective Longitudinal Study of the Effects of Eslicarbazepine Acetate Treatment on Bone Density and Metabolism in Patients with Focal-Onset Epilepsy
por: Hirsch, Martin, et al.
Publicado: (2023)

Sustained seizure remission on perampanel in progressive myoclonic epilepsy (Lafora disease)()
por: Schorlemmer, Kathrin, et al.
Publicado: (2013)

Sleep quality, anxiety, symptoms of depression, and caregiver burden among those caring for patients with Dravet syndrome: a prospective multicenter study in Germany
por: Maltseva, Margarita, et al.
Publicado: (2023)

Clinical characteristics and outcomes of patients with recurrent status epilepticus episodes
por: Bauer, Kristina, et al.
Publicado: (2023)

Direct and indirect costs and cost-driving factors of Tuberous sclerosis complex in children, adolescents, and caregivers: a multicenter cohort study
por: Grau, Janina, et al.
Publicado: (2021)

Effectiveness and Tolerability of 12-Month Brivaracetam in the Real World: EXPERIENCE, an International Pooled Analysis of Individual Patient Records
por: Villanueva, Vicente, et al.
Publicado: (2023)

The burden of illness in Lennox–Gastaut syndrome: a systematic literature review
por: Strzelczyk, Adam, et al.
Publicado: (2023)

Drug-Resistant Juvenile Myoclonic Epilepsy: Misdiagnosis of Progressive Myoclonus Epilepsy
por: Martin, Sarah, et al.
Publicado: (2019)

Wada test results contribute to the prediction of change in verbal learning and verbal memory function after temporal lobe epilepsy surgery
por: Conradi, Nadine, et al.
Publicado: (2021)

Intranasal midazolam as first‐line inhospital treatment for status epilepticus: a pharmaco‐EEG cohort study
por: Kay, Lara, et al.
Publicado: (2019)

Risk incidence of fractures and injuries: a multicenter video-EEG study of 626 generalized convulsive seizures
por: Frey, Katharina, et al.
Publicado: (2020)

Incidence, Risk Factors and Consequences of Epilepsy-Related Injuries and Accidents: A Retrospective, Single Center Study
por: Willems, Laurent M., et al.
Publicado: (2018)

Perampanel for treatment of status epilepticus in Austria, Finland, Germany, and Spain
por: Strzelczyk, Adam, et al.
Publicado: (2019)

Repetitive Electroencephalography as Biomarker for the Prediction of Survival in Patients with Post-Hypoxic Encephalopathy
por: Willems, Laurent M., et al.
Publicado: (2022)

Dravet syndrome: A systematic literature review of the illness burden
por: Strzelczyk, Adam, et al.
Publicado: (2023)

Psychobehavioural and Cognitive Adverse Events of Anti-Seizure Medications for the Treatment of Developmental and Epileptic Encephalopathies
por: Strzelczyk, Adam, et al.
Publicado: (2022)

Levetiracetam and brivaracetam: a review of evidence from clinical trials and clinical experience
por: Steinhoff, Bernhard J., et al.
Publicado: (2019)

Ictal conduction aphasia and ictal angular gyrus syndrome as rare manifestations of epilepsy: The importance of ictal testing during video-EEG monitoring
por: Zöllner, Johann Philipp, et al.
Publicado: (2017)

Limitations of a Short Demographic Questionnaire for Bedside Estimation of Patients’ Global Cognitive Functioning in Epilepsy Patients
por: Gorny, Iris, et al.
Publicado: (2018)

Exploring the relationships between composite scores of disease severity, seizure-freedom and quality of life in Dravet syndrome
por: Strzelczyk, Adam, et al.
Publicado: (2022)

Impfung zur Vorbeugung der COVID-19-Erkrankung sowie Impfpriorisierung bei Epilepsie
por: Strzelczyk, Adam, et al.
Publicado: (2021)

Trends and Differences in Status Epilepticus Treatment of Children and Adults Over 10 Years: A Comparative Study of Medical Records (2012–2021) from a University Hospital in Germany
por: Purwien, Leonore, et al.
Publicado: (2023)

The phenotypic and genotypic spectrum of epilepsy and intellectual disability in adults: Implications for genetic testing
por: von Brauchitsch, Sophie, et al.
Publicado: (2023)

Prospective evaluation of interrater agreement between EEG technologists and neurophysiologists
por: Beuchat, Isabelle, et al.
Publicado: (2021)

Acute and long‐term effects of brivaracetam and brivaracetam–diazepam combinations in an experimental model of status epilepticus
por: Niquet, Jerome, et al.
Publicado: (2017)

A systematic review on the burden of illness in individuals with tuberous sclerosis complex (TSC)
por: Zöllner, Johann Philipp, et al.
Publicado: (2020)

Efficacy and tolerability of brivaracetam monotherapy in childhood and juvenile absence epilepsy: An innovative adaptive trial design
por: Bast, Thomas, et al.
Publicado: (2022)

Impact of COVID-19 pandemic on physical and mental health status and care of adults with epilepsy in Germany
por: Körbel, Kimberly, et al.
Publicado: (2022)

Determinants of quality of life in adults with epilepsy: a multicenter, cross-sectional study from Germany
por: Siebenbrodt, Kai, et al.
Publicado: (2023)

Expanding the Treatment Landscape for Lennox-Gastaut Syndrome: Current and Future Strategies
por: Strzelczyk, Adam, et al.
Publicado: (2021)

Review of the treatment options for epilepsy in tuberous sclerosis complex: towards precision medicine
por: Schubert-Bast, Susanne, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_0k28kgvdet4h21rg53kpvgcq15